The University of Chicago Header Logo

Connection

Kourosh Rezania to Middle Aged

This is a "connection" page, showing publications Kourosh Rezania has written about Middle Aged.
Connection Strength

0.488
  1. Postoperative lumbar paraspinal compartment syndrome. BMJ Case Rep. 2021 Mar 29; 14(3).
    View in: PubMed
    Score: 0.052
  2. ATM mutation in a patient with thymoma-associated myasthenia gravis. Muscle Nerve. 2020 08; 62(2):E50-E52.
    View in: PubMed
    Score: 0.049
  3. Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study. J Immunother. 2019 04; 42(3):94-96.
    View in: PubMed
    Score: 0.046
  4. A Masked Marauder: Hepatitis C Neuropathy. Am J Med. 2018 Jan; 131(1):33-36.
    View in: PubMed
    Score: 0.041
  5. Head-drop: A frequent feature of late-onset myasthenia gravis. Muscle Nerve. 2017 09; 56(3):441-444.
    View in: PubMed
    Score: 0.040
  6. Intermuscular coherence in amyotrophic lateral sclerosis: A preliminary assessment. Muscle Nerve. 2017 06; 55(6):862-868.
    View in: PubMed
    Score: 0.039
  7. Gastrostomy tube placement is safe in advanced amyotrophic lateral sclerosis. Neurol Res. 2017 Jan; 39(1):16-22.
    View in: PubMed
    Score: 0.039
  8. Venous thromboembolism after diaphragm pacing in amyotrophic lateral sclerosis. Muscle Nerve. 2014 Nov; 50(5):863-5.
    View in: PubMed
    Score: 0.033
  9. Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leuk Lymphoma. 2012 Mar; 53(3):371-80.
    View in: PubMed
    Score: 0.027
  10. Impaired glucose tolerance and metabolic syndrome in idiopathic polyneuropathy: the role of pain and depression. Med Hypotheses. 2011 Apr; 76(4):538-42.
    View in: PubMed
    Score: 0.026
  11. Clinical predictors of chimeric antigen receptor T-cell therapy neurotoxicity: a single-center study. Immunotherapy. 2021 10; 13(15):1261-1269.
    View in: PubMed
    Score: 0.014
  12. Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy. Immunotherapy. 2021 01; 13(1):11-17.
    View in: PubMed
    Score: 0.013
  13. Modulation of immune responses by bile acid receptor agonists in myasthenia gravis. J Neuroimmunol. 2020 12 15; 349:577397.
    View in: PubMed
    Score: 0.013
  14. Impaired regulatory B cells in myasthenia gravis. J Neuroimmunol. 2016 08 15; 297:38-45.
    View in: PubMed
    Score: 0.009
  15. Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis. J Clin Pharmacol. 2014 Oct; 54(10):1180-7.
    View in: PubMed
    Score: 0.008
  16. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One. 2013; 8(4):e61177.
    View in: PubMed
    Score: 0.008
  17. Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma. Neurology. 2013 Jan 29; 80(5):e55.
    View in: PubMed
    Score: 0.007
  18. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009 Aug; 66(2):235-44.
    View in: PubMed
    Score: 0.006
  19. How do aphasic and normal speaking subjects restate a message in response to feedback? J Commun Disord. 1989 Feb; 22(1):13-21.
    View in: PubMed
    Score: 0.006
  20. Terbutaline in myasthenia gravis: a pilot study. J Neurol Sci. 2009 Feb 15; 277(1-2):150-4.
    View in: PubMed
    Score: 0.006
  21. A clinical trial of creatine in ALS. Neurology. 2004 Nov 09; 63(9):1656-61.
    View in: PubMed
    Score: 0.004
  22. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with hypertrophic spinal radiculopathy mimicking neurofibromatosis. Acta Neuropathol. 2003 Feb; 105(2):185-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.